Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adults Aged 50 Years and Older”

71 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 71 results

Large-scale testing (Phase 3)Study completedNCT05420961
What this trial is testing

Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-experienced Adults (V116-006, STRIDE-6)

Who this might be right for
Pneumonia, Pneumococcal
Merck Sharp & Dohme LLC 717
Not applicableNot Yet RecruitingNCT06884501
What this trial is testing

Let's Increase Fuerza (Strength) Through Exercise and Diet

Who this might be right for
Older Adults (50-90 Years)CognitionPhysical Activity
University of Illinois at Urbana-Champaign 90
Not applicableActive Not RecruitingNCT06894680
What this trial is testing

Integrating Depression Care Into HIV Services for Older People With HIV Using a Stepped Care, Task-Sharing Approach.

Who this might be right for
Older Adults (50-90 Years)Depression
Royal Society of Tropical Medicine and Hygiene 120
Not applicableStudy completedNCT04831788
What this trial is testing

Pneumococcal Nasopharyngeal and Oropharyngeal Carriage in Adults

Who this might be right for
Preference, Patient
University of Novi Sad 521
Testing effectiveness (Phase 2)Study completedNCT00978029
What this trial is testing

Safety Study of Ragweed Allergy Immunotherapy Tablet in Subjects 50 Years of Age and Older (Study P06081)

Who this might be right for
RhinoconjunctivitisRhinitisConjunctivitis+1 more
ALK-Abelló A/S 203
Large-scale testing (Phase 3)Study completedNCT03439657
What this trial is testing

Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With Prevenar13 in Adults Aged 50 Years and Older

Who this might be right for
Herpes Zoster
GlaxoSmithKline 913
Large-scale testing (Phase 3)Study completedNCT02045836
What this trial is testing

Study to Evaluate Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A When Co-administered With Pneumovax 23™ in Adults Aged 50 Years and Older

Who this might be right for
Herpes ZosterHerpes Zoster Vaccine
GlaxoSmithKline 865
Post-approval studies (Phase 4)Study completedNCT00442975
What this trial is testing

Response of Older Adults to Influenza Vaccination With Regard to Cytomegalovirus (CMV) Status

Who this might be right for
Influenza
Public Health England 100
Testing effectiveness (Phase 2)Study completedNCT00802464
What this trial is testing

Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 Years

Who this might be right for
Herpes Zoster
GlaxoSmithKline 410
Large-scale testing (Phase 3)Active Not RecruitingNCT06873945
What this trial is testing

2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata

Who this might be right for
Alopecia Areata
Pfizer 550
Testing effectiveness (Phase 2)Study completedNCT06695130
What this trial is testing

Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and Recombinant Influenza Vaccine in Adult Participants 50 Years of Age and Older

Who this might be right for
COVID-19 ImmunizationInfluenza Immunization
Sanofi 980
Testing effectiveness (Phase 2)Study completedNCT02547649
What this trial is testing

Safety, Tolerability, and Immunogenicity of Two Formulations of V114 in Healthy Adults 50 Years of Age or Older (V114-006)

Who this might be right for
Pneumococcal Infections
Merck Sharp & Dohme LLC 690
Testing effectiveness (Phase 2)Study completedNCT06695117
What this trial is testing

Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and High-Dose Inactivated Influenza Vaccine in Adult Participants 50 Years of Age and Older

Who this might be right for
COVID-19 ImmunizationInfluenza Immunization
Sanofi 980
Not applicableActive Not RecruitingNCT03558438
What this trial is testing

Spanish Cohort of Patients with HIV Infection Older Than 50 Years for the Study of Fragility and Physical Function

Who this might be right for
HIV InfectionsFrail Older Adults
Fundacion SEIMC-GESIDA 802
Large-scale testing (Phase 3)Ended earlyNCT05993143
What this trial is testing

Ivermectin to Prevent SARS-CoV-2 (COVID-19) Hospitalisation in Subjects Over 50

Who this might be right for
COVID-19SARS-CoV-2
Insud Pharma 249
Large-scale testing (Phase 3)Study completedNCT05219253
What this trial is testing

A Study on the Immune Response and Safety of a Vaccine Against Herpes Zoster in Adults Aged 50 Years and Older in India

Who this might be right for
Herpes Zoster
GlaxoSmithKline 288
Large-scale testing (Phase 3)Study completedNCT05569954
What this trial is testing

Safety and Immunogenicity of V116 in Pneumococcal Vaccine-naïve Adults 50 Years of Age or Older (V116-010, STRIDE-10)

Who this might be right for
Pneumococcal Disease
Merck Sharp & Dohme LLC 1,484
Large-scale testing (Phase 3)Active Not RecruitingNCT07284654
What this trial is testing

Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Immunobridging to Adults 18-49

Who this might be right for
Pneumococcal Vaccines
Vaxcyte, Inc. 4,049
Large-scale testing (Phase 3)Study completedNCT06614725
What this trial is testing

A Study in India on the Immune Response and Safety of a Respiratory Syncytial Virus (RSV) Older Adults (OA) Vaccine When Given to Older Adults 60 Years of Age and Above and Adults 50-59 Years of Age at Increased Risk (AIR) of Respiratory Syncytial Virus Lower Respiratory Tract Disease (RSV-LRTD)

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 751
Testing effectiveness (Phase 2)Study completedNCT05501561
What this trial is testing

Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults ≥50 Years of Age

Who this might be right for
Influenza, Human
Seqirus 1,056
Load More Results